I am a
Home I AM A Search Login

Papers of the Week

2022 Jul 30

Life (Basel)



Long-Term Effectiveness and Safety of Biologic and Small Molecule Drugs for Moderate to Severe Atopic Dermatitis: A Systematic Review.


Ayen-Rodríguez A, Pereyra-Rodríguez J-J, Navarro-Triviño FJ, Alcantara-Luna S, Domínguez-Cruz J, Galán-Gutiérrez M, Vilar-Palomo S, Armario-Hita J C, Ruiz-Villaverde R
Life (Basel). 2022 Jul 30; 12(8).
PMID: 36013338.


Atopic dermatitis (AD) is a genetically based chronic inflammatory dermatosis associated with multiple triggers and complex pathophysiological mechanisms. Nowadays, an authentic therapeutic revolution is taking place with the incorporation of biological drugs for the treatment of moderate and severe atopic dermatitis. A new systematic revision (RS) is necessary to support decision-making for specialists treating AD.